Invivyd, Inc. (IVVD)
NASDAQ: IVVD · IEX Real-Time Price · USD
2.400
-0.050 (-2.04%)
May 17, 2024, 4:00 PM EDT - Market closed
Invivyd Market Cap
Invivyd has a market cap or net worth of $287.55 million as of May 17, 2024. Its market cap has increased by 83.62% in one year.
Market Cap
287.55M
Enterprise Value
99.92M
1-Year Change
83.62%
Ranking
Category
Stock Price
$2.40
Market Cap Chart
Since the IPO on August 6, 2021, Invivyd's market cap has decreased from $1.84B to $287.55M, a decrease of -84.41%. That is a compound annual growth rate of -48.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 17, 2024 | 286.40M | -2.02% |
| May 16, 2024 | 292.30M | -0.41% |
| May 15, 2024 | 293.50M | 1.24% |
| May 14, 2024 | 289.90M | 2.51% |
| May 13, 2024 | 282.80M | 4.86% |
| May 10, 2024 | 269.70M | -6.58% |
| May 9, 2024 | 288.70M | -4.28% |
| May 8, 2024 | 301.60M | 0.80% |
| May 7, 2024 | 299.20M | 6.33% |
| May 6, 2024 | 281.40M | -2.46% |
| May 3, 2024 | 288.50M | 2.09% |
| May 2, 2024 | 282.60M | -2.05% |
| May 1, 2024 | 288.50M | 8.99% |
| Apr 30, 2024 | 264.70M | 6.73% |
| Apr 29, 2024 | 248.00M | -3.24% |
| Apr 26, 2024 | 256.30M | 3.85% |
| Apr 25, 2024 | 246.80M | -2.80% |
| Apr 24, 2024 | 253.90M | -6.17% |
| Apr 23, 2024 | 270.60M | 3.64% |
| Apr 22, 2024 | 261.10M | -4.78% |
| Apr 19, 2024 | 274.20M | -2.14% |
| Apr 18, 2024 | 280.20M | -5.24% |
| Apr 17, 2024 | 295.70M | -8.14% |
| Apr 16, 2024 | 321.90M | -3.91% |
| Apr 15, 2024 | 335.00M | -4.75% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ventyx Biosciences | 295.39M |
| MacroGenics | 294.66M |
| Nyxoah | 294.36M |
| Sanara MedTech | 293.69M |
| Xeris Biopharma Holdings | 293.55M |
| Aquestive Therapeutics | 293.14M |
| Procaps Group | 292.21M |
| Actinium Pharmaceuticals | 289.79M |